Trupanion Primed and Ready to Provide Coverage for Lifesaving Medication for Feline Infectious Peritonitis
- Lifesaving drugs for Feline Infectious Peritonitis are available to treat cats in
The COVID pandemic spurred a slew of new medical research, some of which has provided an unexpected silver lining for our family pets. One is a treatment for an overwhelmingly deadly disease called Feline Infectious Peritonitis (FIP) which is a mutated form of a feline coronavirus. Both domestic and wild cats are susceptible to FIP and it has long been considered fatal regardless of treatment. Not only is this disease fatal, but efforts to treat FIP have been historically fruitless due to a lack of appropriate medication and financial inaccessibility. In fact,
During the pandemic, an antiviral drug called Remdesivir, originally evaluated to treat Ebola many years earlier, was found to inhibit COVID replication in humans. Remdesivir and closely related drugs called metabolites, have since been discovered to successfully treat FIP in cats and have proven results in multiple countries.
As the leading provider of medical insurance for cats and dogs, and the only provider focused on paying veterinary invoices directly to hospitals in real-time,
Dr.
Dr.
Know the signs of FIP in your cat:
All cats, indoors and outdoors, are vulnerable to FIP in the first two years of their lives. Know the signs so you can catch the onset and seek treatment quickly.
- Progressive distention of the abdomen
- Difficulty breathing
- Long lasting fever
- Loss of appetite
- Weight loss
- Depression
- Eye and/or central nervous system signs may occur
Interviews Available
About
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20240515931853r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515931853/en/
Corporate Communications
Corporate.communications@trupanion.com
Source:


Earnix and Exavalu Partner to Help P&C Carriers Modernize Pricing and Rating Flexibility
Jackson Study Reveals Consumers Anxious About Inflation; Financial Professionals Recommend Diversifying
Advisor News
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
More Advisor NewsAnnuity News
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity NewsHealth/Employee Benefits News
- WHITEHOUSE, WYDEN, OSSOFF DEMAND BIG HEALTH INSURANCE CEOS DELIVER ON PROMISES TO REDUCE PATIENT CARE DELAYS
- Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
- Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
- Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
- States get until July to cut Medicaid coverage over work requirement
More Health/Employee Benefits NewsLife Insurance News
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
- Military Briefs: November 19-25
- California’s new solvency rules: What should life insurance advisors watch?
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News